Abstract:Abstract Background: CircRNAs play an important role in tumorigenesis and metastasis, and their expression is comprehensively downregulated in hepatocellular carcinoma (HCC). Previous studies have shown that the polyadenylation signal1 is critical for circRNA expression, while the 3’-end processing complex participates in circRNA cyclization. As a core executor of 3’-end cleavage, we hypothesized that CPSF3 modulates the circularization of circRNA. Methods: The clinical prognostic correlation was analyzed by TCGA database and tissue microarrays. Cytological experiments were performed to determine the role of CPSF3 in the proliferation and migration of HCC cells. The Red/GFP dual fluorescent reporter system was employed to explore the mechanism of RNA back-splicing regulated by CPSF3 protein and PAS sequences. The circRNAs regulated by CPSF3 were screened by RNA-seq and further validated by real-time PCR and dot blotting. Changes in the activity of downstream pathways were explored by various molecular experiments. Finally, the safety and efficacy of the CPSF3 inhibitor JTE-607 were verified by in vitro cytology experiments and in vivo xenograft nude mouse models. Results: CPSF3 was highly expressed in HCC cells and promoted the proliferation and migration of HCC cells. Its high level of expression predicted poor prognosis in HCC patients. Mechanistic study revealed that CPSF3 enhanced RNA cleavage, thereby reducing circRNA levels, increasing linear mRNA levels, and ultimately inhibiting miRNA-mediated gene silencing. Furthermore, the chemical inhibition of CPSF3 by JET-607 suppressed the proliferation of HCC cells both in vitro and in vivo. Conclusions: Our findings indicate that the increased expression of CPSF3 in HCC promotes the shift of pre-mRNA from circRNA to linear mRNA, thereby disrupting miRNA-mediated gene silencing and ultimately leading to uncontrolled cell proliferation. JTE-607, a CPSF3 inhibitor, exerted a therapeutic effect on HCC by blocking CPSF3 activity.

CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma

CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression

CPSF6 Regulates Alternative Polyadenylation and Proliferation of Cancer Cells Through Phase Separation.

NUDT21 Negatively Regulates PSMB2 and CXXC5 by Alternative Polyadenylation and Contributes to Hepatocellular Carcinoma Suppression

Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the VHL 3′UTR in Gastric Cancer Cells

CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p.

CPSF3 modulates the balance of circular and linear transcripts in hepatocellular carcinoma

Activation of YAP1 by N6-Methyladenosine-Modified Circcpsf6 Drives Malignancy in Hepatocellular Carcinoma.

Aberrant Expression of CPSF1 Promotes Head and Neck Squamous Cell Carcinoma Via Regulating Alternative Splicing

Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis

Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression

Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing

Integrated RNA expression and alternative polyadenylation analysis identified CPSF1‐CCDC137 oncogenic axis in lung adenocarcinoma

Cell Cycle Regulation by Alternative Polyadenylation of CCND1.

Cleavage and Polyadenylation Specific Factor 4 Promotes Colon Cancer Progression by Transcriptionally Activating Htert.

CPSF6-mediated XBP1 3'UTR Shortening Attenuates Cisplatin-Induced ER Stress and Elevates Chemo-Resistance in Lung Adenocarcinoma.

Genome-wide Profiling of Polyadenylation Sites Reveals a Link Between Selective Polyadenylation and Cancer Metastasis

SIRT1 Regulates N 6 ‐Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2‐Dependent FTO SUMOylation

Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer

CSTF2 Supports Hypoxia Tolerance in Hepatocellular Carcinoma by Enabling m6A Modification Evasion of PGK1 to Enhance Glycolysis